The Application of Structural Retinal Biomarkers to Evaluate the Effect of Intravitreal Ranibizumab and Dexamethasone Intravitreal Implant on Treatment of Diabetic Macular Edema.
Ida CeravoloGiovanni William OliverioAngela AlibrandiAhsan BhattiLuigi TrombettaRobert RejdakMario Domenico ToroCostantino John TrombettaPublished in: Diagnostics (Basel, Switzerland) (2020)
Ranibizumab and dexamethasone are effective in the treatment of DME, as demonstrated by functional improvement and morphological biomarker change. DME associated with SDN and HRS represents a specific inflammatory pattern for which dexamethasone appears to be more effective.